Ankylosing Spondylitis
📧 Sign up to get email alerts when something new happens for Ankylosing Spondylitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-12-05Clinical Trial Update: Study to Characterize Demographics, Compliance, Tolerability and Safety in Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Prescribed Adalimumab (Humira®) as Part of Routine Clinical Care
This clinical trial update reports demographics, compliance, tolerability, and safety data for patients with rheumatoid arthritis, psoriatic…
-
FDA approval · 2012-12-04FDA Approved: ENBREL — Supplemental Application (Immunex Corporation)
FDA approved a supplemental application for Enbrel (etanercept) submitted by Immunex Corporation.
-
CLINICAL_TRIALS other · 2012-11-30Clinical Trial Update: Resistance Training Exercise Using the Swiss Ball in Ankylosing Spondylitis [NA]
Clinical trial update notes completion of a study evaluating resistance training with a Swiss ball in individuals with Ankylosing Spondyliti…
-
CLINICAL_TRIALS trial_result · 2012-11-08Clinical Trial Update: Study Evaluating Etanercept and Sulphasalazine in Ankylosing Spondylitis [Phase 4]
Phase 4 trial evaluating etanercept with sulfasalazine in ankylosing spondylitis has completed, and results were posted in November 2012.
-
FDA approval · 2012-09-28FDA Approved: HUMIRA — Supplemental Application (Cordavis Limited)
The FDA approved a supplemental application for HUMIRA (adalimumab) submitted by Cordavis Limited.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2012-09-28FDA Approved: INDOMETHACIN — Original Application (Camber Pharmaceuticals, Inc.)
The FDA approved Camber Pharmaceuticals' indomethacin as an original ANDA (generic) application, making Indomethacin available as a generic …
-
CLINICAL_TRIALS research · 2012-09-18Clinical Trial Update: The Usefulness of Interferon-γ Release Assays and Tuberculin Skin Test for Detection of Latent Tuberculosis Infection
This clinical trial update discusses the usefulness of interferon-γ release assays and the tuberculin skin test for detecting latent tubercu…
-
CLINICAL_TRIALS trial_result · 2012-09-12Clinical Trial Update: Post Marketing Surveillance Study of Remicade in Patients With Chronic Inflammatory Diseases (P04840)
A post-marketing surveillance study of infliximab (Remicade) in chronic inflammatory diseases has completed, with results posted in 2012. Th…
-
CLINICAL_TRIALS trial_result · 2012-06-28Clinical Trial Update: Study of the Safety and Efficacy of Golimumab in Chinese Patients With Ankylosing Spondylitis [Phase 3]
Phase 3 clinical trial update reporting results on the safety and efficacy of golimumab in Chinese patients with ankylosing spondylitis.
-
CLINICAL_TRIALS trial_result · 2012-06-19Clinical Trial Update: Study Evaluating Predictors of Response in Patients With Ankylosing Spondylitis
Pfizer conducted a study in Ankylosing Spondylitis to identify predictors of treatment response; results were posted in 2012.
-
FDA approval · 2012-06-13FDA Approved: NAPROXEN SODIUM — Supplemental Application (Bionpharma Inc.)
FDA approved a supplemental application for Naproxen Sodium from Bionpharma Inc., updating the product's regulatory approval.
-
CLINICAL_TRIALS trial_result · 2012-06-06Clinical Trial Update: Observational Study on Non-steroid Anti-inflammatory Drugs (NSAIDs) Treated Patients With Arthritic Disorder
An observational trial update summarizes outcomes for patients with osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis who wer…
-
CLINICAL_TRIALS trial_result · 2012-05-30Clinical Trial Update: Assessment of NSAID-treated Patients Adherence to Co-prescribed Proton Pump Inhibitor (PPI)
This clinical trial update reports on adherence of NSAID-treated patients to co-prescribed proton pump inhibitors in osteoarthritis, rheumat…
-
FDA approval · 2012-05-24FDA Approved: HUMIRA — Supplemental Application (Cordavis Limited)
FDA approved a supplemental application for HUMIRA (adalimumab) submitted by Cordavis Limited.
-
CLINICAL_TRIALS trial_result · 2012-05-11Clinical Trial Update: Extension Study Evaluating Etanercept in Ankylosing Spondylitis [Phase 4]
An extension Phase 4 trial evaluating etanercept in ankylosing spondylitis completed, with results posted in May 2012.
-
FDA approval · 2012-04-17FDA Approved: CIMZIA — Supplemental Application (UCB, Inc.)
The FDA approved a supplemental application for CIMZIA (certolizumab pegol) submitted by UCB, Inc.
-
FDA approval · 2012-03-15FDA Approved: ALEVE GELCAPS — Supplemental Application (Bayer HealthCare LLC.)
FDA approved a supplemental application to add Aleve GelCaps containing naproxen sodium, expanding the approval to include a new dosage form…
-
CLINICAL_TRIALS trial_result · 2012-02-13Clinical Trial Update: Combination Methotrexate and Infliximab [Phase 4]
A Phase 4 clinical trial assessing methotrexate plus infliximab for ankylosing spondylitis has completed.
-
CLINICAL_TRIALS trial_result · 2012-02-01Clinical Trial Update: Remicade Safety Line (Ankylosing Spondylitis)(Study P03275)(COMPLETED)
Completed clinical trial update for Remicade in ankylosing spondylitis (Study P03275) with results posted.
-
CLINICAL_TRIALS trial_result · 2012-01-26Clinical Trial Update: Effect Of Anti TNF Alpha Therapy And Their Adverse Effects In Ankylosing Spondylitis In A North Indian Population [NA]
A completed clinical trial from the All India Institute of Medical Sciences assessing anti-TNF alpha therapy and its adverse effects in pati…
-
CLINICAL_TRIALS trial_result · 2012-01-19Clinical Trial Update: Efficacy and Safety of Kunxian Capsule in Treatment Patients With Early Ankylosing Spondylitis [Phase 4]
Phase 4 clinical trial assessing efficacy and safety of Kunxian Capsule in early ankylosing spondylitis has completed.
-
FDA approval · 2011-12-26FDA Approved: HUMIRA — Supplemental Application (Cordavis Limited)
The FDA has approved a supplemental application for Humira (adalimumab) submitted by Cordavis Limited.
-
FDA approval · 2011-12-13FDA Approved: HUMIRA — Supplemental Application (Cordavis Limited)
FDA approved a supplemental application for HUMIRA (adalimumab) filed by Cordavis Limited.
-
CLINICAL_TRIALS trial_result · 2011-11-16Clinical Trial Update: PReventive Efficacy and Safety of rEbamipide on Nsaid Induced Mucosal Toxicity [Phase 3]
Phase 3 trial evaluating the preventive efficacy and safety of rebamipide for NSAID-induced mucosal toxicity in rheumatoid arthritis and rel…
-
FDA approval · 2011-11-08FDA Approved: NAPROXEN — Original Application (Aurobindo Pharma Limited)
The FDA approved Aurobindo Pharma Limited's original application for a generic naproxen product. Naproxen is a nonsteroidal anti-inflammator…